Opinion|Videos|March 12, 2026
ASCO GU recap: Sam Chang, MD, on KEYNOTE-B15, SWOG S1602
Author(s)Sam S. Chang, MD, MBA
Fact checked by: Hannah Clarke
Sam S. Chang, MD, MBA, highlights 2 studies presented at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco, California, that he believes are particularly impactful for clinicians treating bladder cancer.
Advertisement
Advertisement
In the following video, Sam S. Chang, MD, MBA, highlights 2 studies presented at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco, California, that he believes are particularly impactful for clinicians treating bladder cancer. Chang highlighted data in both non–muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC), emphasizing findings that may directly influence clinical decision-making.
Advertisement
Advertisement
